COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03786289
Recruitment Status : Completed
First Posted : December 26, 2018
Last Update Posted : October 8, 2020
Information provided by (Responsible Party):
Tianjin SinoBiotech Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 3, 2019
Actual Study Completion Date : December 9, 2019